Home/Pipeline/VeriDose DPYD Plus Panel

VeriDose DPYD Plus Panel

Pharmacogenetics - Oncology

CommercialActive

Key Facts

Indication
Pharmacogenetics - Oncology
Phase
Commercial
Status
Active
Company

About Agena Bioscience

Agena Bioscience is a provider of targeted genomic analysis solutions, centered on its proprietary MassARRAY System which combines PCR with MALDI-TOF mass spectrometry. The company serves the research and clinical diagnostics markets with a focus on pharmacogenetics, oncology mutation profiling, hereditary genetics, and sample integrity testing. As a division of Mesa Labs, Agena operates globally with a business model based on selling instruments, consumable assays, and related services to molecular laboratories.

View full company profile